Company profile: Tavec Pharma
1.1 - Company Overview
Company description
- Provider of injectable cancer therapies using exosome-mediated delivery technology. The company enables delivery by injection of anti-cancer molecules, including regulatory RNA, directly to cancer cells to disrupt growth and metastasis.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tavec Pharma
Provista Diagnostics
HQ: United States
Website
- Description: Provider of blood-based diagnostic tests focused on oncology, including Videssa Breast Cancer Test combining serum protein biomarkers and tumor-associated autoantibodies for high-accuracy detection in women with abnormal imaging findings. Also offers COVID-19 PCR testing with same-day results from car-based collection, Long COVID panel, FDA-EUA real-time qPCR respiratory tests, UTI PCR testing, and wound infection testing with antibiotic resistance assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Provista Diagnostics company profile →
MS-Omics
HQ: Denmark
Website
- Description: Provider of metabolomics and data analysis services for small to large studies, offering fee-for-service analyses to universities and companies in biotechnology, pharmacy, and food. Capabilities include microbiome metabolite measurement (with Clinical-Microbiomics for next-generation sequencing), clinical, cell and bacteria, nutritional, and animal metabolomics, leveraging advanced mass spectrometry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MS-Omics company profile →
Stokes Bio
HQ: Ireland
Website
- Description: Provider of microfluidic technology and systems for genetic analysis, developing and distributing microfluidics solutions to clients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stokes Bio company profile →
Variantyx
HQ: United States
Website
- Description: Provider of molecular diagnostics specializing in advanced genetic testing: PCR-free whole genome sequencing for uniform coverage and detection of clinically relevant variants; IriSight tests for SNVs, indels, structural, repeat expansions, mitochondrial variants; Genomic Intelligence analytical software; OncoAlly tumor profiling using WGS, WES and RNA; and ClaudIA for Genomics producing actionable reports for cancer treatment management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Variantyx company profile →
BridgeBio Pharma
HQ: United States
Website
- Description: Provider of precision medicines for genetic diseases and cancers, developing assets including BBP-398 (SHP2 inhibitor for MAPK/RAS-driven cancers), BBP-631 (AAV5 gene therapy for congenital adrenal hyperplasia), BBP-818 (AAV gene therapy for classic galactosemia), BBP-589 (recombinant collagen 7 for dystrophic epidermolysis bullosa), BBP-681 (topical PI3KA inhibitor), and BBP-711 (GO inhibitor).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BridgeBio Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tavec Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tavec Pharma
2.2 - Growth funds investing in similar companies to Tavec Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tavec Pharma
4.2 - Public trading comparable groups for Tavec Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →